LITS
Lite Strategy, Inc.
Key Financials
Revenue
$0
↓ 100.0%
Total Liabilities
$1.1M
↓ 21.0%
Net Income
$-71150000
↓ 346.2%
Shareholders' Equity
$41.6M
↑ 145.8%
EPS (Diluted)
$-2.06
↑ 13.8%
Cash & Equivalents
$5.7M
↓ 68.3%
Total Assets
$42.7M
↑ 133.5%
Operating Cash Flow
$-9121000.00
↑ 56.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 9/28/2026 | View on SEC |
| S-3 | 9/28/2026 | View on SEC |
| 10-K | 9/28/2026 | View on SEC |
| SCHEDULE 13G/A | 8/3/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 8-K | 7/24/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| SCHEDULE 13G/A | 2/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LITS |
| Company Name | Lite Strategy, Inc. |
| CIK | 1262104 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 858-369-7100 |